Your browser doesn't support javascript.
loading
A Pilot Trial of the Combination of Transgenic NY-ESO-1-reactive Adoptive Cellular Therapy with Dendritic Cell Vaccination with or without Ipilimumab.
Nowicki, Theodore S; Berent-Maoz, Beata; Cheung-Lau, Gardenia; Huang, Rong Rong; Wang, Xiaoyan; Tsoi, Jennifer; Kaplan-Lefko, Paula; Cabrera, Paula; Tran, Justin; Pang, Jia; Macabali, Mignonette; Garcilazo, Ivan Perez; Carretero, Ignacio Baselga; Kalbasi, Anusha; Cochran, Alistair J; Grasso, Catherine S; Hu-Lieskovan, Siwen; Chmielowski, Bartosz; Comin-Anduix, Begoña; Singh, Arun; Ribas, Antoni.
Afiliación
  • Nowicki TS; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of California Los Angeles, Los Angeles, California.
  • Berent-Maoz B; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, California.
  • Cheung-Lau G; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, California.
  • Huang RR; Department of Pathology, University of California Los Angeles, Los Angeles, California.
  • Wang X; Department of General Internal Medicine and Health Services Research, University of California Los Angeles, Los Angeles, California.
  • Tsoi J; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, California.
  • Kaplan-Lefko P; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, California.
  • Cabrera P; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, California.
  • Tran J; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, California.
  • Pang J; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, California.
  • Macabali M; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, California.
  • Garcilazo IP; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, California.
  • Carretero IB; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, California.
  • Kalbasi A; Division of Molecular and Cellular Oncology, Department of Radiation Oncology, University of California Los Angeles, Los Angeles, California.
  • Cochran AJ; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.
  • Grasso CS; Division of Surgical-Oncology, Department of Surgery, University of California Los Angeles, Los Angeles, California.
  • Hu-Lieskovan S; Department of Pathology, University of California Los Angeles, Los Angeles, California.
  • Chmielowski B; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, California.
  • Comin-Anduix B; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, California.
  • Singh A; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, California.
  • Ribas A; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.
Clin Cancer Res ; 25(7): 2096-2108, 2019 04 01.
Article en En | MEDLINE | ID: mdl-30573690
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Dendríticas / Vacunas contra el Cáncer / Traslado Adoptivo / Ipilimumab / Antineoplásicos Inmunológicos / Neoplasias Tipo de estudio: Guideline Límite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Dendríticas / Vacunas contra el Cáncer / Traslado Adoptivo / Ipilimumab / Antineoplásicos Inmunológicos / Neoplasias Tipo de estudio: Guideline Límite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article